Metastat Inc (MTST) Financial Statements (2024 and earlier)

Company Profile

Business Address 27 DRYDOCK AVE., 2ND FLOOR
BOSTON, MA 02210
State of Incorp. NV
Fiscal Year End February 28
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

2/28/2018
Q4
11/30/2017
Q3
8/31/2017
Q2
5/31/2017
Q1
2/28/2017
Q4
11/30/2016
Q3
8/31/2016
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7821,7341527831,85086
Cash and cash equivalents7821,7341527831,85086
Receivables   23   
Prepaid expense7241412152104
Deferred costs      
Total current assets:8531,7752168041,902190
Noncurrent Assets
Property, plant and equipment377399392415428450
Other undisclosed noncurrent assets444444444444
Total noncurrent assets:421442436458471493
TOTAL ASSETS:1,2742,2176521,2622,373683
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7857499367681,0401,563
Interest and dividends payable17161616849
Accounts payable4235326695728141,241
Accrued liabilities345201252180219274
Debt1,0009989949898271,793
Other undisclosed current liabilities119271106193500108
Total current liabilities:1,9042,0192,0361,9502,3673,464
Noncurrent Liabilities
Liabilities, other than long-term debt, including:49961452,1073,696227
Derivative instruments and hedges, liabilities84961452,1073,696227
Other undisclosed liabilities, other than long-term debt (35)     
Other undisclosed noncurrent liabilities84     
Total noncurrent liabilities:133961452,1073,696227
Total liabilities:2,0372,1152,1814,0576,0633,691
Equity
Equity, attributable to parent, including:(762)102(1,530)(2,795)(3,690)(3,007)
Common stock110000
Additional paid in capital27,76527,45925,06523,52323,17222,469
Accumulated deficit(28,528)(27,358)(26,595)(26,319)(26,863)(25,477)
Other undisclosed equity, attributable to parent000000
Total equity:(762)102(1,530)(2,795)(3,690)(3,007)
TOTAL LIABILITIES AND EQUITY:1,2742,2176521,2622,373683

Income Statement (P&L) ($ in thousands)

2/28/2018
Q4
11/30/2017
Q3
8/31/2017
Q2
5/31/2017
Q1
2/28/2017
Q4
11/30/2016
Q3
8/31/2016
Q2
Revenues   23   
Gross profit:   23   
Operating expenses(1,153)(783)(760)(831)(718)(972)
Other operating income (expense), net
(Other Expenses)
  204611,375(668)93
Other undisclosed operating income      
Operating income (loss):(1,153)(763)(276)544(1,387)(880)
Nonoperating expense
(Other Nonoperating expense)
(17)     
Interest and debt expense(30)(30)(30)(2,625)1,249(402)
Loss from continuing operations:(1,200)(793)(306)(2,080)(138)(1,281)
Loss before gain (loss) on sale of properties:(1,200)(793)(306)(2,080)(138)(1,281)
Other undisclosed net income (loss)3030302,625(1,249)402
Net income (loss) attributable to parent:(1,170)(763)(276)544(1,387)(880)
Other undisclosed net loss available to common stockholders, basic(25)(56)(23)(31)(2,361)(103)
Net income (loss) available to common stockholders, diluted:(1,195)(819)(300)514(3,747)(982)

Comprehensive Income ($ in thousands)

2/28/2018
Q4
11/30/2017
Q3
8/31/2017
Q2
5/31/2017
Q1
2/28/2017
Q4
11/30/2016
Q3
8/31/2016
Q2
Net income (loss):(1,170)(763)(276)544(1,387)(880)
Comprehensive income (loss), net of tax, attributable to parent:(1,170)(763)(276)544(1,387)(880)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: